ReP USP - Resultado da busca

Artigo de periodico
TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis (2022)
Duarte, Victor Hugo Rezende ; Cruz, Marina Sampaio; Bertolami, Adriana; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Luchessi, André Ducati ; Silbiger, Vivian Nogueira
Fonte: Scientifc Reports. Unidade: FCF
Assuntos: LEUCÓCITOS, ARTERIOSCLEROSE, BIOMARCADORES, CARDIOLOGIA, BIOLOGIA MOLECULAR, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE, Victor Hugo Rezende et al. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis. Scientifc Reports, v. 12, p. 1-9 art. 18612, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-22040-3. Acesso em: 12 jul. 2024.
APA
Duarte, V. H. R., Cruz, M. S., Bertolami, A., Hirata, M. H., Hirata, R. D. C., Luchessi, A. D., & Silbiger, V. N. (2022). TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis. Scientifc Reports, 12, 1-9 art. 18612. doi:10.1038/s41598-022-22040-3
NLM
Duarte VHR, Cruz MS, Bertolami A, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis [Internet]. Scientifc Reports. 2022 ; 12 1-9 art. 18612.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1038/s41598-022-22040-3
Vancouver
Duarte VHR, Cruz MS, Bertolami A, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis [Internet]. Scientifc Reports. 2022 ; 12 1-9 art. 18612.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1038/s41598-022-22040-3
Artigo de periodico
Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts (2022)
Hernandez, Carolina Dagli ; Zhou, Yitian; Lauschke, Volker Martin; Genvigir, Fabiana Dalla Vecchia ; Hirata, Thiago Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Pharmacological Reports. Unidade: FCF
Assuntos: ESTATINAS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, v. 74, p. 47–66, 2022Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00319-y. Acesso em: 12 jul. 2024.
APA
Hernandez, C. D., Zhou, Y., Lauschke, V. M., Genvigir, F. D. V., Hirata, T. D. C., Hirata, M. H., & Hirata, R. D. C. (2022). Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports, 74, 47–66. doi:10.1007/s43440-021-00319-y
NLM
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1007/s43440-021-00319-y
Vancouver
Hernandez CD, Zhou Y, Lauschke VM, Genvigir FDV, Hirata TDC, Hirata MH, Hirata RDC. Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts [Internet]. Pharmacological Reports. 2022 ; 74 47–66.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1007/s43440-021-00319-y
Artigo de periodico
Inhibitor induced conformational changes in SARS-COV-2 papain-like protease (2022)
Ferreira, Glaucio Monteiro ; Pillaiyar, Thanigaimalai ; Hirata, Mario Hiroyuki ; Poso, Antti ; Kronenberger, Thales
Fonte: Scientifc Reports. Unidade: FCF
Assuntos: COVID-19, LIGANTES, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. Inhibitor induced conformational changes in SARS-COV-2 papain-like protease. Scientifc Reports, v. 12, p. 1-13 art. 11585, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-15181-y. Acesso em: 12 jul. 2024.
APA
Ferreira, G. M., Pillaiyar, T., Hirata, M. H., Poso, A., & Kronenberger, T. (2022). Inhibitor induced conformational changes in SARS-COV-2 papain-like protease. Scientifc Reports, 12, 1-13 art. 11585. doi:10.1038/s41598-022-15181-y
NLM
Ferreira GM, Pillaiyar T, Hirata MH, Poso A, Kronenberger T. Inhibitor induced conformational changes in SARS-COV-2 papain-like protease [Internet]. Scientifc Reports. 2022 ; 12 1-13 art. 11585.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1038/s41598-022-15181-y
Vancouver
Ferreira GM, Pillaiyar T, Hirata MH, Poso A, Kronenberger T. Inhibitor induced conformational changes in SARS-COV-2 papain-like protease [Internet]. Scientifc Reports. 2022 ; 12 1-13 art. 11585.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1038/s41598-022-15181-y
Artigo de periodico
Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells (2021)
Cerda, Alvaro ; Bortolin, Raul Hernandes ; Manriquez, Victor; Salazar, Luis A ; Zambrano, Tomás ; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Pharmacological Reports. Unidade: FCF
Assuntos: MICRORNAS, LIPÍDEOS, MICRORNAS, EXPRESSÃO GÊNICA, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, v. 73, p. 1-13 art. 868–880, 2021Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00241-3. Acesso em: 12 jul. 2024.
APA
Cerda, A., Bortolin, R. H., Manriquez, V., Salazar, L. A., Zambrano, T., Fajardo, C. M., et al. (2021). Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, 73, 1-13 art. 868–880. doi:10.1007/s43440-021-00241-3
NLM
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Vancouver
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Trabalho de evento-resumo periodico
Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events (2018)
Hernandez, Carolina Dagli; Borges, Jéssica Bassani; Los, Bruna; Faludi, André Arpad; Gonçalves, Rodrigo Marques; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Drug Metabolism and Personalized Therapy. Nome do evento: Santorini Conference Systems Medicine and Personalised Health & Therapy. Unidade: FCF
Assuntos: ESTATINAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events. Drug Metabolism and Personalized Therapy. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.1515/dmpt-2018-0024. Acesso em: 12 jul. 2024. , 2018
APA
Hernandez, C. D., Borges, J. B., Los, B., Faludi, A. A., Gonçalves, R. M., Hirata, M. H., & Hirata, R. D. C. (2018). Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events. Drug Metabolism and Personalized Therapy. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1515/dmpt-2018-0024
NLM
Hernandez CD, Borges JB, Los B, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events [Internet]. Drug Metabolism and Personalized Therapy. 2018 ; 33( 3): eA52-eA53.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1515/dmpt-2018-0024
Vancouver
Hernandez CD, Borges JB, Los B, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Rare variants in CYP2C9 and CYP3A5 detected in patients with familial hypercholesterolemia with statin-related adverse events [Internet]. Drug Metabolism and Personalized Therapy. 2018 ; 33( 3): eA52-eA53.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1515/dmpt-2018-0024
Artigo de periodico
Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population (2018)
Manriquez, Victor; Aviles, Jorge; Salazar, Luís; Saavedra, Nicolás; Seron, Pamela; Lanas, Fernando; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro
Fonte: Molecular Diagnosis & Therapy. Unidade: FCF
Assuntos: POLIMORFISMO, LEPTINA, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANRIQUEZ, Victor et al. Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population. Molecular Diagnosis & Therapy, v. 22, n. 1, p. 101-113, 2018Tradução . . Disponível em: https://doi.org/10.1007/s40291-017-0306-8. Acesso em: 12 jul. 2024.
APA
Manriquez, V., Aviles, J., Salazar, L., Saavedra, N., Seron, P., Lanas, F., et al. (2018). Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population. Molecular Diagnosis & Therapy, 22( 1), 101-113. doi:10.1007/s40291-017-0306-8
NLM
Manriquez V, Aviles J, Salazar L, Saavedra N, Seron P, Lanas F, Fajardo CM, Hirata MH, Hirata RDC, Cerda A. Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population [Internet]. Molecular Diagnosis & Therapy. 2018 ; 22( 1): 101-113.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1007/s40291-017-0306-8
Vancouver
Manriquez V, Aviles J, Salazar L, Saavedra N, Seron P, Lanas F, Fajardo CM, Hirata MH, Hirata RDC, Cerda A. Polymorphisms in genes involved in the Leptin-Melanocortin pathway are associated with Obesity-Related cardiometabolic alterations in a southern chilean population [Internet]. Molecular Diagnosis & Therapy. 2018 ; 22( 1): 101-113.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1007/s40291-017-0306-8
Artigo de periodico
Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure?: A randomized clinical trial (2017)
Kawauchi, Tatiana Satie; Umeda, Iracema Ioco Kikuchi; Braga, Lays Magalhães; Mansur, Antonio de Padua; Rossi Neto, João Manoel; Sousa, Amanda Guerra de Moraes Rego; Hirata, Mario Hiroyuki ; Cahalin, Lawrence P; Nakagawa, Naomi Kondo
Fonte: Clinical research in cardiology : official journal of the German Cardiac Society. Unidades: FM, FCF
Assuntos: EXERCÍCIOS DE RESISTÊNCIA MUSCULAR, MÚSCULOS DO SISTEMA RESPIRATÓRIO, INSUFICIÊNCIA CARDÍACA, CORAÇÃO, CAPACIDADE FUNCIONAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAWAUCHI, Tatiana Satie et al. Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure?: A randomized clinical trial. Clinical research in cardiology : official journal of the German Cardiac Society, v. 95, n. 09, p. 676-685, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00392-017-1089-y. Acesso em: 12 jul. 2024.
APA
Kawauchi, T. S., Umeda, I. I. K., Braga, L. M., Mansur, A. de P., Rossi Neto, J. M., Sousa, A. G. de M. R., et al. (2017). Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure?: A randomized clinical trial. Clinical research in cardiology : official journal of the German Cardiac Society, 95( 09), 676-685. doi:10.1007/s00392-017-1089-y
NLM
Kawauchi TS, Umeda IIK, Braga LM, Mansur A de P, Rossi Neto JM, Sousa AG de MR, Hirata MH, Cahalin LP, Nakagawa NK. Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure?: A randomized clinical trial [Internet]. Clinical research in cardiology : official journal of the German Cardiac Society. 2017 ; 95( 09): 676-685.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1007/s00392-017-1089-y
Vancouver
Kawauchi TS, Umeda IIK, Braga LM, Mansur A de P, Rossi Neto JM, Sousa AG de MR, Hirata MH, Cahalin LP, Nakagawa NK. Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure?: A randomized clinical trial [Internet]. Clinical research in cardiology : official journal of the German Cardiac Society. 2017 ; 95( 09): 676-685.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1007/s00392-017-1089-y
Artigo de periodico
Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure? A randomized clinical trial (2017)
Kawauchi, Tatiana Satie; Umeda, Iracema Ioco Kikuchi; Braga, Lays Magalhães; Mansur, Antonio de Padua; Rossi Neto, João Manoel; Sousa, Amanda Guerra de Moraes Rego; Hirata, Mario Hiroyuki ; Cahalin, Lawrence P; Nakagawa, Naomi Kondo
Fonte: Clinical Research in Cardiology. Unidades: FM, FCF
Assuntos: MÚSCULOS DO SISTEMA RESPIRATÓRIO, INSUFICIÊNCIA CARDÍACA, REABILITAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAWAUCHI, Tatiana Satie et al. Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure? A randomized clinical trial. Clinical Research in Cardiology, v. 106, n. 9, p. 676-685, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00392-017-1089-y. Acesso em: 12 jul. 2024.
APA
Kawauchi, T. S., Umeda, I. I. K., Braga, L. M., Mansur, A. de P., Rossi Neto, J. M., Sousa, A. G. de M. R., et al. (2017). Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure? A randomized clinical trial. Clinical Research in Cardiology, 106( 9), 676-685. doi:10.1007/s00392-017-1089-y
NLM
Kawauchi TS, Umeda IIK, Braga LM, Mansur A de P, Rossi Neto JM, Sousa AG de MR, Hirata MH, Cahalin L P, Nakagawa NK. Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure? A randomized clinical trial [Internet]. Clinical Research in Cardiology. 2017 ; 106( 9): 676-685.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1007/s00392-017-1089-y
Vancouver
Kawauchi TS, Umeda IIK, Braga LM, Mansur A de P, Rossi Neto JM, Sousa AG de MR, Hirata MH, Cahalin L P, Nakagawa NK. Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure? A randomized clinical trial [Internet]. Clinical Research in Cardiology. 2017 ; 106( 9): 676-685.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1007/s00392-017-1089-y
Artigo de periodico
Pharmacogenetics of drug metabolizing enzymes in Brazilian populations (2014)
Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Drug Metabolism and Interactions. Unidade: FCF
Assuntos: FARMACOGENÉTICA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations. Drug Metabolism and Interactions, v. 29, n. 3, p. 153-177, 2014Tradução . . Disponível em: https://doi.org/10.1515/dmdi-2013-0067. Acesso em: 12 jul. 2024.
APA
Cerda, A., Hirata, M. H., & Hirata, R. D. C. (2014). Pharmacogenetics of drug metabolizing enzymes in Brazilian populations. Drug Metabolism and Interactions, 29( 3), 153-177. doi:10.1515/dmdi-2013-0067
NLM
Cerda A, Hirata MH, Hirata RDC. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations [Internet]. Drug Metabolism and Interactions. 2014 ; 29( 3): 153-177.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1515/dmdi-2013-0067
Vancouver
Cerda A, Hirata MH, Hirata RDC. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations [Internet]. Drug Metabolism and Interactions. 2014 ; 29( 3): 153-177.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1515/dmdi-2013-0067
Trabalho de evento-resumo periodico
Anti-inflammatory effects of cholesterol-lowering drugs in TNF'alfa'-induced endothelial cells (2012)
Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Drug Metabolism and Drug Interactions. Nome do evento: Santorine Conference Biologie Prospective. Unidade: FCF
Assuntos: CÉLULAS ENDOTELIAIS, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Anti-inflammatory effects of cholesterol-lowering drugs in TNF'alfa'-induced endothelial cells. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 12 jul. 2024. , 2012
APA
Cerda, A., Hirata, M. H., & Hirata, R. D. C. (2012). Anti-inflammatory effects of cholesterol-lowering drugs in TNF'alfa'-induced endothelial cells. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Cerda A, Hirata MH, Hirata RDC. Anti-inflammatory effects of cholesterol-lowering drugs in TNF'alfa'-induced endothelial cells. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A23 res. B1.[citado 2024 jul. 12 ]
Vancouver
Cerda A, Hirata MH, Hirata RDC. Anti-inflammatory effects of cholesterol-lowering drugs in TNF'alfa'-induced endothelial cells. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A23 res. B1.[citado 2024 jul. 12 ]
Trabalho de evento-resumo periodico
Expression of mir-33a/b in hepatoma cells treated with atorvastatin (2012)
Zambrano, T; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Salazar, Luís Antônio
Fonte: Drug Metabolism and Drug Interactions. Nome do evento: Santorine Conference Biologie Prospective. Unidade: FCF
Assuntos: EXPRESSÃO GÊNICA, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAMBRANO, T et al. Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 12 jul. 2024. , 2012
APA
Zambrano, T., Cerda, A., Hirata, M. H., Hirata, R. D. C., & Salazar, L. A. (2012). Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Zambrano T, Cerda A, Hirata MH, Hirata RDC, Salazar LA. Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A34 res. B28.[citado 2024 jul. 12 ]
Vancouver
Zambrano T, Cerda A, Hirata MH, Hirata RDC, Salazar LA. Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A34 res. B28.[citado 2024 jul. 12 ]
Trabalho de evento-resumo periodico
Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients (2012)
Luchessi, André Ducati; Germano, J. F; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Silbiger, Vivian Nogueira; Brion, M; Carracedo, A; Tanajura, Luiz Fernando Leite; Lima, P. H. O; Hirata, Thiago Dominguez Crespo; Sousa, A. G
Fonte: Drug Metabolism and Drug Interactions. Nome do evento: Santorine Conference Biologie Prospective. Unidade: FCF
Assuntos: POLIMORFISMO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCHESSI, André Ducati et al. Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 12 jul. 2024. , 2012
APA
Luchessi, A. D., Germano, J. F., Hirata, M. H., Hirata, R. D. C., Silbiger, V. N., Brion, M., et al. (2012). Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Luchessi AD, Germano JF, Hirata MH, Hirata RDC, Silbiger VN, Brion M, Carracedo A, Tanajura LFL, Lima PHO, Hirata TDC, Sousa AG. Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A28 res. B14.[citado 2024 jul. 12 ]
Vancouver
Luchessi AD, Germano JF, Hirata MH, Hirata RDC, Silbiger VN, Brion M, Carracedo A, Tanajura LFL, Lima PHO, Hirata TDC, Sousa AG. Relationship of CYP2C9, CYP2C19 and ABCC3 polymorphisms and platelet response to aspirin and clopidogrel in acute coronary syndrome patients. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A28 res. B14.[citado 2024 jul. 12 ]
Trabalho de evento-resumo periodico
Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe (2012)
Guimarães, E; Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Dórea, Egidio Lima; Pinto, Gelba Almeida; Gusukuma, Maria Cecília; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Drug Metabolism and Drug Interactions. Nome do evento: Santorine Conference Biologie Prospective. Unidades: HU, FCF
Assuntos: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, HIPERGLICEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, E et al. Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe. Drug Metabolism and Drug Interactions. Berlin: Hospital Universitário, Universidade de São Paulo. . Acesso em: 12 jul. 2024. , 2012
APA
Guimarães, E., Cerda, A., Genvigir, F. D. V., Dórea, E. L., Pinto, G. A., Gusukuma, M. C., et al. (2012). Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe. Drug Metabolism and Drug Interactions. Berlin: Hospital Universitário, Universidade de São Paulo.
NLM
Guimarães E, Cerda A, Genvigir FDV, Dórea EL, Pinto GA, Gusukuma MC, Hirata MH, Hirata RDC. Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A26 res. B8.[citado 2024 jul. 12 ]
Vancouver
Guimarães E, Cerda A, Genvigir FDV, Dórea EL, Pinto GA, Gusukuma MC, Hirata MH, Hirata RDC. Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A26 res. B8.[citado 2024 jul. 12 ]
Trabalho de evento-resumo periodico
Clopidogrel downregulates TNF'alfa'-induced ICAM1 and IL8 expressions in endothelial cells (2012)
Cerda, Alvaro; Luchessi, Augusto Ducati; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Drug Metabolism and Drug Interactions. Nome do evento: Santorine Conference Biologie Prospective. Unidade: FCF
Assuntos: CÉLULAS ENDOTELIAIS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Clopidogrel downregulates TNF'alfa'-induced ICAM1 and IL8 expressions in endothelial cells. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 12 jul. 2024. , 2012
APA
Cerda, A., Luchessi, A. D., Hirata, M. H., & Hirata, R. D. C. (2012). Clopidogrel downregulates TNF'alfa'-induced ICAM1 and IL8 expressions in endothelial cells. Drug Metabolism and Drug Interactions. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Cerda A, Luchessi AD, Hirata MH, Hirata RDC. Clopidogrel downregulates TNF'alfa'-induced ICAM1 and IL8 expressions in endothelial cells. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A24 res. B2.[citado 2024 jul. 12 ]
Vancouver
Cerda A, Luchessi AD, Hirata MH, Hirata RDC. Clopidogrel downregulates TNF'alfa'-induced ICAM1 and IL8 expressions in endothelial cells. Drug Metabolism and Drug Interactions. 2012 ; 27( 3): A24 res. B2.[citado 2024 jul. 12 ]
Artigo de periodico
Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport (2012)
Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Drug Metabolism and Drug Interactions. Unidade: FCF
Assuntos: LIPOPROTEÍNAS LDL, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport. Drug Metabolism and Drug Interactions, v. 27, n. 2, p. 101-111, 2012Tradução . . Disponível em: https://doi.org/10.1515/dmdi-2012-0007. Acesso em: 12 jul. 2024.
APA
Cerda, A., Hirata, M. H., & Hirata, R. D. C. (2012). Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport. Drug Metabolism and Drug Interactions, 27( 2), 101-111. doi:10.1515/dmdi-2012-0007
NLM
Cerda A, Hirata MH, Hirata RDC. Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport [Internet]. Drug Metabolism and Drug Interactions. 2012 ; 27( 2): 101-111.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1515/dmdi-2012-0007
Vancouver
Cerda A, Hirata MH, Hirata RDC. Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport [Internet]. Drug Metabolism and Drug Interactions. 2012 ; 27( 2): 101-111.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1515/dmdi-2012-0007
Artigo de periodico
Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database (2012)
Andrade, Mauricio Pacheco de; Hirata, Rosario Dominguez Crespo ; Sandrini, Fabiano; Largura, Alvaro; Hirata, Mario Hiroyuki
Fonte: Clinical Chemistry and Laboratory Medicine. Unidade: FCF
Assuntos: ÁCIDO ÚRICO, BANCO DE DADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Mauricio Pacheco de et al. Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database. Clinical Chemistry and Laboratory Medicine, v. 50, n. 5, p. 853-859, 2012Tradução . . Disponível em: https://doi.org/10.1515/cclm-2011-0150. Acesso em: 12 jul. 2024.
APA
Andrade, M. P. de, Hirata, R. D. C., Sandrini, F., Largura, A., & Hirata, M. H. (2012). Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database. Clinical Chemistry and Laboratory Medicine, 50( 5), 853-859. doi:10.1515/cclm-2011-0150
NLM
Andrade MP de, Hirata RDC, Sandrini F, Largura A, Hirata MH. Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database [Internet]. Clinical Chemistry and Laboratory Medicine. 2012 ; 50( 5): 853-859.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1515/cclm-2011-0150
Vancouver
Andrade MP de, Hirata RDC, Sandrini F, Largura A, Hirata MH. Uric acid biorhythm, a feature of long-term variation in a clinical laboratory database [Internet]. Clinical Chemistry and Laboratory Medicine. 2012 ; 50( 5): 853-859.[citado 2024 jul. 12 ] Available from: https://doi.org/10.1515/cclm-2011-0150
Trabalho de evento-resumo periodico
Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals (2010)
Himelfarb, Silvia Tchernin; Silva, F. A; Arazi, Simone Sorkin; Farjado, C. M; Oliveira, Raquel; Bertolami, Marcelo Chiara; Rezende, A. A; Bertolami, A; Faludi, A; Sampaio, M. F; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidade: FCF
Assuntos: DIABETES MELLITUS, BIOMARCADORES, LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIMELFARB, Silvia Tchernin et al. Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 12 jul. 2024. , 2010
APA
Himelfarb, S. T., Silva, F. A., Arazi, S. S., Farjado, C. M., Oliveira, R., Bertolami, M. C., et al. (2010). Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Himelfarb ST, Silva FA, Arazi SS, Farjado CM, Oliveira R, Bertolami MC, Rezende AA, Bertolami A, Faludi A, Sampaio MF, Hirata RDC, Hirata MH. Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A67 res. B12.[citado 2024 jul. 12 ]
Vancouver
Himelfarb ST, Silva FA, Arazi SS, Farjado CM, Oliveira R, Bertolami MC, Rezende AA, Bertolami A, Faludi A, Sampaio MF, Hirata RDC, Hirata MH. Effects of pioglitazone on PPARG, TNFA and osteoprotegerin expression in leukocytes and bone turnover biomarkers in diabetic individuals. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A67 res. B12.[citado 2024 jul. 12 ]
Trabalho de evento-resumo periodico
Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells (2010)
Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Hirata, Mario Hiroyuki ; Curi, Rui; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidades: FCF, ICB
Assuntos: EXPRESSÃO GÊNICA, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 12 jul. 2024. , 2010
APA
Genvigir, F. D. V., Rodrigues, A. C., Hirata, M. H., Curi, R., & Hirata, R. D. C. (2010). Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Genvigir FDV, Rodrigues AC, Hirata MH, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A66 res. B11.[citado 2024 jul. 12 ]
Vancouver
Genvigir FDV, Rodrigues AC, Hirata MH, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in Caco-2 cells. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A66 res. B11.[citado 2024 jul. 12 ]
Trabalho de evento-resumo periodico
Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients (2010)
Luchessi, André Ducati; Silbiger, Vivian Nogueira; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro; Carracedo, A; Brion, Marcel; Iñigues, A; Bravo, M. S; Bastos, G; Sousa, A. G. M. R; Hirata, Mario Hiroyuki
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidade: FCF
Assunto: EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCHESSI, André Ducati et al. Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 12 jul. 2024. , 2010
APA
Luchessi, A. D., Silbiger, V. N., Hirata, R. D. C., Cerda, A., Carracedo, A., Brion, M., et al. (2010). Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Luchessi AD, Silbiger VN, Hirata RDC, Cerda A, Carracedo A, Brion M, Iñigues A, Bravo MS, Bastos G, Sousa AGMR, Hirata MH. Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A69 res. B19.[citado 2024 jul. 12 ]
Vancouver
Luchessi AD, Silbiger VN, Hirata RDC, Cerda A, Carracedo A, Brion M, Iñigues A, Bravo MS, Bastos G, Sousa AGMR, Hirata MH. Clopidogrel response is affected by ABCC3 expression but not ABCB1 in CAD patients. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A69 res. B19.[citado 2024 jul. 12 ]
Trabalho de evento-resumo periodico
Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population (2010)
Oliveira, Raquel; Genvigir, Fabiana Dalla Vecchia; Cerda, Alvaro; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Jorge, M. E. I; Fajardo, Cristina Moreno ; Crema, Daniela; Machado, J. E. A; Martinez, M. B; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Fonte: Clinical Chemistry and Laboratory Medicine. Nome do evento: Santorini Conference Biologie Prospective. Unidades: HU, FCF
Assuntos: POLIMORFISMO, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Raquel et al. Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo. . Acesso em: 12 jul. 2024. , 2010
APA
Oliveira, R., Genvigir, F. D. V., Cerda, A., Dórea, E. L., Bernik, M. M. S., Jorge, M. E. I., et al. (2010). Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. Berlin: Hospital Universitário, Universidade de São Paulo.
NLM
Oliveira R, Genvigir FDV, Cerda A, Dórea EL, Bernik MMS, Jorge MEI, Fajardo CM, Crema D, Machado JEA, Martinez MB, Hirata MH, Hirata RDC. Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A56-A56 res. A24.[citado 2024 jul. 12 ]
Vancouver
Oliveira R, Genvigir FDV, Cerda A, Dórea EL, Bernik MMS, Jorge MEI, Fajardo CM, Crema D, Machado JEA, Martinez MB, Hirata MH, Hirata RDC. Polymorphism of the gene of Lep, LEPR, AdipoQ and IL-6 and possible involvement in obesity and diabetes mellitus in Brazilian population. Clinical Chemistry and Laboratory Medicine. 2010 ; 48( 8): A56-A56 res. A24.[citado 2024 jul. 12 ]

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Nome do evento

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos